RETRACTION: FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway (Retraction of Vol 23, Pg 9978, 2019)

被引：4
|
作者：
Li, Z. -Q. [1 ]
Qu, M. [1 ]
Wan, H. -X. [1 ]
Wang, H. [1 ]
Deng, Q. [1 ]
Zhang, Y. [1 ]
机构：
[1] Sanya Peoples Hosp, Dept Oncol, Sanya, Peoples R China
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2021年 / 25卷 / 05期
关键词：
D O I：
10.26355/eurrev_202103_25247
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2159 / 2159
页数：1
相关论文
共 50 条
  • [1] RETRACTED: FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway (Retracted article. See vol. 25, pg. 2159, 2021)
    Li, Z. -Q.
    Qu, M.
    Wan, H. -X.
    Wang, H.
    Deng, Q.
    Zhang, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 9978 - 9987
  • [2] FOXK1 Promotes Proliferation and Metastasis of Gallbladder Cancer by Activating AKT/mTOR Signaling Pathway
    Ma, Wencong
    Wang, Jinghan
    Yu, Yong
    Ao, Jianyang
    Li, Bin
    Cheng, Qingbao
    Liu, Chen
    Jiang, Xiaoqing
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] RETRACTION: MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway (Retraction of Vol 23, Pg 3611, 2019)
    Chen, B.
    Zheng, Z. -Y.
    Yang, J. -Z.
    Li, X. -G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (08) : 3145 - 3145
  • [4] RETRACTION: Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway (Retraction of Vol 23, Pg 10549, 2019)
    Wang, Y. -Y.
    Cheng, X. -D.
    Jiang, H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (17) : 7881 - 7881
  • [5] RETRACTION: Long noncoding RNA OR3A4 promotes the migration and invasion of melanoma through the PI3K/AKT signaling pathway (Retraction of Vol 23, Pg 6991, 2019)
    Wu, J.
    Zhou, M. -Y.
    Yu, X. -P.
    Wu, Y.
    Xie, P. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 10917 - 10917
  • [6] RETRACTION: LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway (Retraction of Vol 22, Pg 6315, 2018)
    Lei, Y.
    Wang, Y. -H.
    Wang, X. -F.
    Bai, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (06) : 2460 - 2460
  • [7] RETRACTION: Znhit1 inhibits breast cancer by up-regulating PTEN to deactivate the PI3K/Akt/mTOR pathway (Retraction of Vol 224, Pg 204, 2019)
    Cui, Chunguo
    Li, Sijie
    Wu, Di
    LIFE SCIENCES, 2022, 305
  • [8] RETRACTION: Sapylin inhibits lung cancer cell proliferation and promotes apoptosis by attenuating PI3K/AKT signaling (Retraction of Vol 2019, Pg 14679, 2019)
    Zhang, Lin
    Liu, Benhong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S42 - S42
  • [9] NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mTOR signaling pathway
    Zhu, Liao-Liao
    Shi, Jing-Jie
    Guo, Yong-Dong
    Yang, Cheng
    Wang, Rong-Lin
    Li, Shan-Shan
    Gan, Dong-Xue
    Ma, Pei-Xiang
    Li, Jun-Qiang
    Su, Hai-Chuan
    NEOPLASMA, 2023, 70 (02) : 272 - 286
  • [10] RETRACTION: Promethazine inhibits neuronal apoptosis via PI3K/Akt signaling pathway in rats with cerebral infarction (Retraction of Vol 23, Pg 126, 2019)
    Pan, X. -D.
    Chen, X. -L.
    Ding, S. -F.
    Kou, D.
    Hu, H. -L.
    Li, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (01) : 4 - 4
12345